🇺🇸 FDA
Pipeline program

Micafungin

ACN-MA-MYC-registry-2013

Approved small_molecule terminated

Quick answer

Micafungin for Aspergillosis is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Aspergillosis
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials